Skip to content
Nox FoundryRequest a diagnostic

Nox Intelligence

Intelligence built for a decision.

Nox Intelligence follows regulatory change, technology deployment and corridor pressure. Each note identifies the commercial consequence, the evidence gap and the next decision.

Robotics deployment readiness across the China to Europe corridor
NOX / CONTROLLED FRAME

Latest briefings

Two substantive briefings each month. Updated when the underlying decision changes.

Editorial standardsNox Intelligence RSS (EN) ↗
Governance Note

Governance for international expansion.

Official context, management consequences and the client outcomes Nox Foundry supports when an international commitment changes the accountability leadership must hold.

Read the briefing
Capability Note

International distributor appointments, made decision-ready.

How Nox Foundry frames the mandate, coordinates material workstreams and turns uncertainty around a proposed distributor into an accountable commercial decision.

Read the briefing
Regulatory Radar

The 2 August 2026 AI Act milestone changes the leadership timetable.

Article 50 transparency obligations now apply, and the Commission has entered full enforcement of the general-purpose AI obligations already in force. The Digital Omnibus moved the high-risk dates, but it did not remove the need for accountable decisions.

Read the briefing
Corridor Note

China-to-EU robotics: deployability now sits inside the commercial case.

EU deployment readiness now sits beside product performance. The commercial case increasingly depends on clear accountability across the route to market.

Read the briefing
Field Note

CIFIT, Hangzhou and Shanghai bring two China business events into view.

September 2026 places the investment fair in Xiamen and Luxembourg’s official mission to Hangzhou and Shanghai within the same month, giving leadership a broader view of the China market.

Read the briefing

Begin

Bring us the complexity.

We will frame the mandate, expose the missing evidence and define the first decision.

Request a diagnostic